PRKCI and cervical cancer: In cervical cancer, PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway 43, and Garcinone C inhibits the tumorigenic and invasive potential of CRC stem-like cells by targeting the Hedgehog/GLI1 signaling pathway 44.